Mom says doctors dismissed these early signs her 2-year-old had a brain tumor: 'Didn't feel right'
Gracelyn Stiffler, 2, had headaches, vomiting and started walking differently. They were signs of a brain tumor, but doctors ...
Doctors said I had panic attacks — it was actually an incurable brain tumor
A young woman has been diagnosed with an incurable brain tumor after doctors dismissed her symptoms - as panic attacks.
Agawam woman sues Pfizer over birth control she believes gave her brain tumor
Provera, Kelly Wright says she began experiencing "alarming" symptoms, including severe migraines and vision impairment.
TV Host Shares Emotional Video After Surgery for ‘Very Rare’ Brain Tumor: 'I Just Feel Very Lucky'
British TV Host Davina McCall posted an emotional video discussing her recovery from brain surgery on Instagram on Monday, ...
US Weekly on MSN3d
British TV Host Davina McCall Is ‘Unbelievably Grateful’ After Brain Surgery for ‘Very Rare’ Tumor
British TV host Davina McCall shared an emotional update after undergoing brain surgery for a ‘very rare’ tumor ...
Medpage Today on MSN6d
AMA President-Elect Confronts a New Challenge: A Brain Tumor
Things came to a head earlier this month at the AMA's interim meeting in Orlando, Florida. Mukkamala, who is the AMA Board of ...
FOX 4 Dallas-Fort Worth on MSN3h
Rockwall woman survives brain tumor, returns to same hospital as nurse
Erica Cash went from a patient at Texas Health Rockwall to one of its news licensed vocational nurse. But she says the ...
John Deere surprises 2-year-old battling brain tumor
Everything green and yellow came to life for two-year-old Everett Redman on Friday at John Deere. In the middle of his ...
Psychology Today5d
A First-of-Its-Kind Explainable AI Model Detects Brain Cancer
A unique combination of explainable AI and repurposing animal camouflage detection algorithms can identify human brain cancer ...
Brain Tumor Drugs Market To Reach USD 5.25 Billion By 2032, Driven By Advances In Targeted Therapies And Immunotherapies
Brain Tumor Drugs Market To Reach USD 5.25 Billion By 2032, Driven By Advances In Targeted Therapies And Immunotherapies Increasing demand for personalized treatment approaches & the growing ...